These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1273 related articles for article (PubMed ID: 28303904)

  • 1. Microbiota: a key orchestrator of cancer therapy.
    Roy S; Trinchieri G
    Nat Rev Cancer; 2017 May; 17(5):271-285. PubMed ID: 28303904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cancer immunotherapy efficacy by gut microbiota.
    Huo S; Liu L; Liu J; Li Q; Wang J
    Discov Med; 2019 Feb; 27(147):93-100. PubMed ID: 30939293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbes and Cancer.
    Dzutsev A; Badger JH; Perez-Chanona E; Roy S; Salcedo R; Smith CK; Trinchieri G
    Annu Rev Immunol; 2017 Apr; 35():199-228. PubMed ID: 28142322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
    Hekmatshoar Y; Rahbar Saadat Y; Hosseiniyan Khatibi SM; Ozkan T; Zununi Vahed F; Nariman-Saleh-Fam Z; Pourghassem Gargari B; Sunguroglu A; Zununi Vahed S
    Life Sci; 2019 Sep; 233():116680. PubMed ID: 31344431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients.
    Gately S
    Cancer Treat Res; 2019; 178():253-264. PubMed ID: 31209849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota-myeloid cell crosstalk beyond the gut.
    Gorjifard S; Goldszmid RS
    J Leukoc Biol; 2016 Nov; 100(5):865-879. PubMed ID: 27605211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gut microbiota and efficacy of cancer therapies].
    Vétizou M; Daillère R; Zitvogel L
    Biol Aujourdhui; 2017; 211(1):51-67. PubMed ID: 28682227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer.
    Carbone C; Piro G; Di Noia V; D'Argento E; Vita E; Ferrara MG; Pilotto S; Milella M; Cammarota G; Gasbarrini A; Tortora G; Bria E
    Mediators Inflamm; 2019; 2019():7652014. PubMed ID: 31827379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of gut microbiota and metabolites in cancer chemotherapy.
    Li S; Zhu S; Yu J
    J Adv Res; 2024 Oct; 64():223-235. PubMed ID: 38013112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy.
    Dzutsev A; Goldszmid RS; Viaud S; Zitvogel L; Trinchieri G
    Eur J Immunol; 2015 Jan; 45(1):17-31. PubMed ID: 25328099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic cell death: A link between gut microbiota and anticancer effects.
    Chen W; Wang S; Wu Y; Shen X; Guo Z; Li Q; Xing D
    Microb Pathog; 2020 Apr; 141():103983. PubMed ID: 31954823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.
    Gori S; Inno A; Belluomini L; Bocus P; Bisoffi Z; Russo A; Arcaro G
    Crit Rev Oncol Hematol; 2019 Nov; 143():139-147. PubMed ID: 31634731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
    Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
    Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of microbiota in cancer therapy.
    Perez-Chanona E; Trinchieri G
    Curr Opin Immunol; 2016 Apr; 39():75-81. PubMed ID: 26820225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The microbiome and cancer for clinicians.
    Picardo SL; Coburn B; Hansen AR
    Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gut Microbiota in Causation, Detection, and Treatment of Cancer.
    Murphy CL; OʼToole PW; Shanahan F
    Am J Gastroenterol; 2019 Jul; 114(7):1036-1042. PubMed ID: 30848738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome.
    Pitt JM; Vétizou M; Waldschmitt N; Kroemer G; Chamaillard M; Boneca IG; Zitvogel L
    Cancer Res; 2016 Aug; 76(16):4602-7. PubMed ID: 27474734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the commensal microbiota on distal tumor-promoting inflammation.
    Buchta Rosean CM; Rutkowski MR
    Semin Immunol; 2017 Aug; 32():62-73. PubMed ID: 28687194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.